PAPER Vann AS
SEARCH RESULTS
331395 RESULTS
PAPER Gardner RC, Yaffe K
Traumatic brain injury may increase risk of young onset dementia.
Ann Neurol. 2014 Mar;75(3):339-41. Epub 2014 Mar 7 PubMed: 24550062PAPER Alva G, Isaacson R, Sadowsky C, Grossberg G, Meng X, Somogyi M
Efficacy of higher-dose 13.3 mg/24 h (15 cm(2)) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
Int J Geriatr Psychiatry. 2014 Sep;29(9):920-7. Epub 2014 Feb 18 PubMed: 24549933PAPER Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
JAMA. 2014 Feb 19;311(7):682-91. PubMed: 24549548PAPER Inestrosa NC, Varela-Nallar L
Wnt signaling in the nervous system and in Alzheimer's disease.
J Mol Cell Biol. 2014 Feb;6(1):64-74. PubMed: 24549157PAPER Schmidt C, Becker H, Peter C, Lange K, Friede T, Zerr I
Plasma prion protein concentration and progression of Alzheimer disease.
Prion. 2014 Feb 18;8(2) PubMed: 24549099PAPER Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M, ICTUS/DSA Group
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
Phytomedicine. 2014 May 15;21(6):888-92. Epub 2014 Feb 16 PubMed: 24548724PAPER Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, Goate AM, Alzheimer’s Disease Neuroimaging Initiative
Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.
Biol Psychiatry. 2014 May 1;75(9):723-31. Epub 2014 Jan 19 PubMed: 24548642PAPER Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB, Alzheimer's Disease Neuroimaging Initiative
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.
Prog Neurobiol. 2014 Jun;117:20-40. Epub 2014 Feb 16 PubMed: 24548606PAPER Zhang J, Li Y, Xu J, Yang Z
The role of N-methyl-D-aspartate receptor in Alzheimer's disease.
J Neurol Sci. 2014 Apr 15;339(1-2):123-9. Epub 2014 Feb 6 PubMed: 24548486PAPER Rosen HJ, Alcantar O, Zakrzewski J, Shimamura AP, Neuhaus J, Miller BL
Metacognition in the behavioral variant of frontotemporal dementia and Alzheimer's disease.
Neuropsychology. 2014 May;28(3):436-47. Epub 2014 Feb 17 PubMed: 24548124PAPER Youn K, Yun EY, Lee J, Kim JY, Hwang JS, Jeong WS, Jun M
Oleic acid and linoleic acid from Tenebrio molitor larvae inhibit BACE1 activity in vitro: molecular docking studies.
J Med Food. 2014 Feb;17(2):284-9. PubMed: 24548007PAPER Lockhart C, Klimov DK
Alzheimer's Aβ10-40 peptide binds and penetrates DMPC bilayer: an isobaric-isothermal replica exchange molecular dynamics study.
J Phys Chem B. 2014 Mar 13;118(10):2638-48. Epub 2014 Feb 28 PubMed: 24547901PAPER Nouh A, Borys E, Gierut AK, Biller J
Amyloid-Beta related angiitis of the central nervous system: case report and topic review.
Front Neurol. 2014;5:13. Epub 2014 Feb 4 PubMed: 24550886PAPER Liu ME, Huang CC, Yang AC, Tu PC, Yeh HL, Hong CJ, Liou YJ, Chen JF, Chou KH, Lin CP, Tsai SJ
Catechol-O-methyltransferase Val158Met polymorphism on the relationship between white matter hyperintensity and cognition in healthy people.
PLoS One. 2014;9(2):e88749. Epub 2014 Feb 13 PubMed: 24551149Current Filters
No filters selected